Inotiv Inc
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences researc… Read more
Inotiv Inc (NOTV) - Total Assets
Latest total assets as of December 2025: $734.34 Million USD
Based on the latest financial reports, Inotiv Inc (NOTV) holds total assets worth $734.34 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Inotiv Inc - Total Assets Trend (1997–2025)
This chart illustrates how Inotiv Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Inotiv Inc - Asset Composition Analysis
Current Asset Composition (September 2025)
Inotiv Inc's total assets of $734.34 Million consist of 25.2% current assets and 74.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.8% |
| Accounts Receivable | $97.45 Million | 12.6% |
| Inventory | $45.74 Million | 5.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $240.20 Million | 31.2% |
| Goodwill | $94.29 Million | 12.2% |
Asset Composition Trend (1997–2025)
This chart illustrates how Inotiv Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Inotiv Inc's current assets represent 25.2% of total assets in 2025, a decrease from 33.3% in 1997.
- Cash Position: Cash and equivalents constituted 2.8% of total assets in 2025, up from 1.3% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 43.0% of total assets, an increase from 1.0% in 1997.
- Asset Diversification: The largest asset category is intangible assets at 31.2% of total assets.
Inotiv Inc Competitors by Total Assets
Key competitors of Inotiv Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Inotiv Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Inotiv Inc generates 0.67x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Inotiv Inc is currently not profitable relative to its asset base.
Inotiv Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.30 | 1.57 | 0.50 |
| Quick Ratio | 0.22 | 1.28 | 0.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-374.77 Million | $ 62.29 Million | $ -18.20 Million |
Inotiv Inc - Advanced Valuation Insights
This section examines the relationship between Inotiv Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.12 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -1.3% |
| Total Assets | $771.11 Million |
| Market Capitalization | $12.21 Million USD |
Valuation Analysis
Below Book Valuation: The market values Inotiv Inc's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Inotiv Inc's assets decreased by 1.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Inotiv Inc (1997–2025)
The table below shows the annual total assets of Inotiv Inc from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $771.11 Million | -1.31% |
| 2024-09-30 | $781.36 Million | -8.78% |
| 2023-09-30 | $856.53 Million | -11.05% |
| 2022-09-30 | $962.90 Million | +199.17% |
| 2021-09-30 | $321.86 Million | +422.55% |
| 2020-09-30 | $61.59 Million | +46.72% |
| 2019-09-30 | $41.98 Million | +34.26% |
| 2018-09-30 | $31.27 Million | +53.15% |
| 2017-09-30 | $20.42 Million | -3.42% |
| 2016-09-30 | $21.14 Million | -11.24% |
| 2015-09-30 | $23.82 Million | +0.17% |
| 2014-09-30 | $23.77 Million | -7.12% |
| 2013-09-30 | $25.60 Million | -5.11% |
| 2012-09-30 | $26.98 Million | -16.60% |
| 2011-09-30 | $32.35 Million | +8.75% |
| 2010-09-30 | $29.74 Million | -8.72% |
| 2009-09-30 | $32.59 Million | -19.24% |
| 2008-09-30 | $40.35 Million | -4.02% |
| 2007-09-30 | $42.04 Million | -0.65% |
| 2006-09-30 | $42.31 Million | -11.55% |
| 2005-09-30 | $47.84 Million | +2.23% |
| 2004-09-30 | $46.80 Million | +4.02% |
| 2003-09-30 | $44.99 Million | +34.43% |
| 2002-09-30 | $33.46 Million | +19.61% |
| 2001-09-30 | $27.98 Million | +4.93% |
| 2000-09-30 | $26.66 Million | +1.38% |
| 1999-09-30 | $26.30 Million | +17.94% |
| 1998-09-30 | $22.30 Million | +40.25% |
| 1997-09-30 | $15.90 Million | -- |